C. E. Desantis, F. Bray, J. Ferlay, J. Lortet-tieulent, B. O. Anderson et al., International Variation in Female Breast Cancer Incidence and Mortality Rates, Cancer Epidemiol. Biomarkers Prev, vol.24, pp.1495-1506, 2015.

F. J. Couch, K. L. Nathanson, and K. Offit, Two decades after BRCA: Setting paradigms in personalized cancer care and prevention, vol.343, pp.1466-1470, 2014.

K. B. Kuchenbaecker, J. L. Hopper, D. R. Barnes, K. A. Phillips, T. M. Mooij et al., Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers, JAMA, vol.317, pp.2402-2416, 2017.

H. D. Nelson, M. Pappas, B. Zakher, J. P. Mitchell, L. Okinaka-hu et al., Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: A systematic review to update the U.S. Preventive Services Task Force recommendation, Ann. Intern. Med, vol.160, pp.255-266, 2014.

F. J. Couch, H. Shimelis, C. Hu, S. N. Hart, E. C. Polley et al., Associations between Cancer Predisposition Testing Panel Genes and Breast Cancer, JAMA Oncol, vol.3, pp.1190-1196, 2017.

A. W. Kurian, A. C. Antoniou, and S. M. Domchek, Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information, Am. Soc. Clin. Oncol. Educ. Book, vol.35, pp.44-56, 2016.

J. Doherty, D. C. Bonadies, and E. T. Matloff, Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice, J. Genet. Couns, vol.24, pp.683-687, 2014.

A. W. Kurian, E. E. Hare, M. A. Mills, K. E. Kingham, L. Mcpherson et al., Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment, J. Clin. Oncol, vol.32, 2001.

T. P. Slavin, M. Niell-swiller, I. Solomon, B. Nehoray, C. Rybak et al., Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management, Front. Oncol, vol.5, 2015.

D. Gadzicki, D. G. Evans, H. Harris, C. Julian-reynier, I. Nippert et al., Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany, J. Community Genet, vol.2, pp.53-69, 2011.

R. Resta, B. B. Biesecker, R. L. Bennett, S. Blum, S. E. Hahn et al., National Society of Genetic Counselors' Definition Task Force. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report, J. Genet. Couns, vol.15, pp.77-83, 2006.

B. D. Riley, J. O. Culver, C. Skrzynia, L. A. Senter, J. A. Peters et al., Essential elements of genetic cancer risk assessment, counseling, and testing: Updated recommendations of the National Society of Genetic Counselors, J. Genet. Couns, vol.21, pp.151-161, 2012.

W. Carr and S. Wolfe, Unmet needs as sociomedical indicators, Int. J. Health Serv, vol.6, pp.417-430, 1976.

J. Vos, C. J. Van-asperen, J. C. Oosterwijk, F. H. Menko, M. J. Collee et al., The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: Not only psychopathology matters, Psychooncology, vol.22, pp.902-910, 2013.

A. Richardson, J. Medina, V. Brown, and J. Sitzia, Patients' needs assessment in cancer care: A review of assessment tools. Support Care Cancer, vol.15, pp.1125-1144, 2007.

D. Cella, C. Hughes, A. Peterman, C. H. Chang, B. N. Peshkin et al., A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol, vol.21, pp.564-572, 2002.

W. Eijzenga, E. M. Bleiker, D. E. Hahn, I. Kluijt, G. N. Sidharta et al., Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: Development and testing of a screening questionnaire for use in clinical cancer genetics, Psychooncology, vol.23, pp.862-869, 2014.

P. K. Han, W. M. Klein, and N. K. Arora, Varieties of uncertainty in health care: A conceptual taxonomy, Med. Decis. Making, vol.31, pp.828-838, 2011.

B. Meiser, J. Irle, E. Lobb, and K. Barlow-stewart, Assessment of the content and process of genetic counseling: A critical review of empirical studies, J. Genet. Couns, vol.17, pp.434-451, 2008.

A. H. Pieterse, A. M. Van-dulmen, F. A. Beemer, J. M. Bensing, and M. G. Ausems, Cancer genetic counseling: Communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment, J. Genet. Couns, vol.16, pp.85-96, 2007.

J. Vos, F. H. Menko, J. C. Oosterwijk, C. J. Van-asperen, A. M. Stiggelbout et al., Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: An explorative assessment, Psychooncology, vol.22, pp.1167-1176, 2013.

D. F. Easton, P. D. Pharoah, A. C. Antoniou, M. Tischkowitz, S. V. Tavtigian et al., Gene-panel sequencing and the prediction of breast-cancer risk, N. Engl. J. Med, vol.372, pp.2243-2257, 2015.

D. M. Eccles, G. Mitchell, A. N. Monteiro, R. Schmutzler, F. J. Couch et al., BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance, Ann. Oncol, vol.26, pp.2057-2065, 2015.

K. A. Kaphingst, J. Ivanovich, B. B. Biesecker, R. Dresser, J. Seo et al., Preferences for Return of Incidental Findings from Genome Sequencing among Women Diagnosed with Breast Cancer at a Young Age, Clin. Genet, vol.89, pp.378-384, 2016.

M. Harvie, A. Howell, and D. G. Evans, Can diet and lifestyle prevent breast cancer: What is the evidence?, Am. Soc. Clin. Oncol. Educ. Book, pp.66-73, 2015.

A. Brédart, J. L. Kop, A. C. Griesser, C. Fiszer, K. Zaman et al., Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care, Ann. Oncol, vol.24, pp.2151-2158, 2013.

C. Julian-reynier, A. D. Bouhnik, D. G. Evans, H. Harris, C. J. Van-asperen et al., Nippert, I. General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles, BMC Cancer, vol.15, p.243, 2015.

W. W. Lam, A. H. Au, J. H. Wong, C. Lehmann, U. Koch et al., Unmet supportive care needs: A cross-cultural comparison between Hong Kong Chinese and German Caucasian women with breast cancer, Breast Cancer Res. Treat, vol.130, pp.531-541, 2011.

A. R. Bradbury, L. J. Patrick-miller, B. L. Egleston, L. Digiovanni, J. Brower et al., Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing, Genet. Med, vol.18, pp.25-33, 2016.

H. S. Lumish, H. Steinfeld, C. Koval, D. Russo, E. Levinson et al., Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients, J. Genet. Couns, vol.26, pp.1116-1129, 2017.

D. Kuli?, A. Bottomley, G. Velikova, E. Greimel, and M. Koller, , 2017.

D. Razavi, N. Delvaux, C. Farvacques, and E. Robaye, Screening for adjustment disorders and major depressive disorders in cancer in-patients, Br. J. Psychiatry, vol.156, pp.79-83, 1990.

C. Herrmann-lingen, U. Buss, R. P. Snaith, and . Hads-d, Hospital Anxiety and Depression Scale-German, 2011.

A. J. Lee, A. P. Cunningham, K. B. Kuchenbaecker, N. Mavaddat, D. F. Easton et al., BOADICEA breast cancer risk prediction model: Updates to cancer incidences, tumour pathology and web interface, Br. J. Cancer, vol.110, pp.535-545, 2014.

M. Watson, C. Foster, R. Eeles, D. Eccles, S. Ashley et al., Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort, Br. J. Cancer, vol.91, pp.1787-1794, 2004.

A. Farrelly, V. White, B. Meiser, M. Jefford, M. A. Young et al., Unmet support needs and distress among women with a BRCA1/2 mutation, Fam. Cancer, vol.12, pp.509-518, 2013.

A. Oberguggenberger, M. Sztankay, R. J. Morscher, B. Sperner-unterweger, I. Weber et al., Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study, J. Psychosom. Res, vol.89, pp.39-45, 2016.

P. Bennett, C. Phelps, J. Hilgart, K. Hood, K. Brain et al., Concerns and coping during cancer genetic risk assessment, Psychooncology, vol.21, pp.611-617, 2012.

M. Bjornslett, A. A. Dahl, O. Sorebo, and A. Dorum, Psychological distress related to BRCA testing in ovarian cancer patients, Fam. Cancer, vol.14, pp.495-504, 2015.

W. Eijzenga, E. M. Bleiker, D. E. Hahn, L. E. Van-der-kolk, G. N. Sidharta et al., Prevalence and detection of psychosocial problems in cancer genetic counseling, Fam. Cancer, vol.14, pp.629-636, 2015.

C. H. Halbert, J. E. Stopfer, J. Mcdonald, B. Weathers, A. Collier et al., Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: Does time heal women's concerns?, J. Clin. Oncol, vol.29, pp.4302-4306, 2011.

C. Phelps, P. Bennett, H. Jones, K. Hood, K. Brain et al., The development of a cancer genetic-specific measure of coping: The GRACE, Psychooncology, vol.19, pp.847-854, 2010.

N. A. Kasparian, C. E. Wakefield, and B. Meiser, Assessment of psychosocial outcomes in genetic counseling research: An overview of available measurement scales, J. Genet. Couns, vol.16, pp.693-712, 2007.

K. Payne, S. Nicholls, M. Mcallister, R. Macleod, D. Donnai et al., Outcome measurement in clinical genetics services: A systematic review of validated measures, Value Health, vol.11, pp.497-508, 2008.

K. Redlinger-grosse, P. M. Veach, S. Cohen, B. S. Leroy, I. M. Macfarlane et al., Defining Our Clinical Practice: The Identification of Genetic Counseling Outcomes Utilizing the Reciprocal Engagement Model, J. Genet. Couns, vol.25, pp.239-257, 2016.